Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)

NCT07577609 · tracked via the Priya Life Science Ireland tracker
Phase
Observational
Started
2022-12-21
Last updated
2026-05-11

Condition(s) studied

Coronary Artery Disease (CAD)Computed Tomography AngiographyBiomarkersAI (Artificial Intelligence)Lipoprotein(a)Atheroscleroses, CoronaryMyocardial Ischemia

Study summary

The goal of this observational study is to learn if AI-assisted cardiac CT imaging can improve cardiovascular risk stratification and prediction of future coronary events in an adult population undergoing clinically indicated cardiac CT.

The main questions it aims to answer are:

* Can AI-enhanced cardiac CT accurately assess cardiovascular risk in a real-world adult population?
* How do CT-derived plaque characteristics correlate with clinical, biochemical, and lifestyle risk factors? Researchers will compare subgroups (e.g., patients with different risk profiles, biomarkers, or imaging findings, and a subset undergoing OCT imaging) to see if differences in imaging and clinical parameters are associated with cardiovascular risk and plaque vulnerability.

Participants will:

* Provide informed consent and medical history/demographic information
* Undergo blood sampling for cardiovascular and metabolic biomarkers
* Have a resting ECG performed
* Complete a detailed lifestyle and health questionnaire
* Receive a non-invasive cardiac CT scan interpreted by an expert
* Potentially receive heart rate-lowering medication (e.g., metoprolol) if required for imaging quality
* Be referred for further clinical evaluation if clinically indicated 

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Adults aged ≥18 years * Undergoing clinically indicated cardiac CT * Able and willing to provide informed consent Exclusion Criteria: * History of malignancy * Abnormal renal function (e.g., eGFR or serum creatinine outside reference range) * Contraindications to iodinated contrast agents or CT imaging

Primary outcome measure(s)

  • Cardiovascular risk stratification using AI-assisted cardiac CT — Baseline
    Assessment of cardiovascular risk based on AI-enhanced cardiac CT imaging, including coronary artery calcium scoring, plaque characterization, and integrated risk prediction using clinical and imaging data.

Trial sites (1)

FacilityCityRegionStatus
Clinical Research Facility Galway Ireland Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07577609 on ClinicalTrials.gov ↗ ← All trials in Ireland